Skip to main content
. 2002 May;46(5):1574–1576. doi: 10.1128/AAC.46.5.1574-1576.2002

TABLE 1.

Activities of erythromycin, clindamycin, and tetracycline against 54 erythromycin-resistant and 55 erythromycin- susceptible S. agalactiae isolates

Organisms (no. of isolates tested) and antimicrobial agent MICa (μg/ml)
50% 90% Range
Erythromycin-resistant isolates (54)
    Erythromycin 4 >64 1->64
    Clindamycin 16 >64 0.03->64
    Tetracycline 32 64 0.05-64
Erythromycin-susceptible isolates (55)
    Erythromycin 0.03 0.03 0.01-0.06
    Clindamycin 0.03 0.06 0.03-0.06
    Tetracycline 16 32 0.01-64
a

Breakpoints from the NCCLS for resistant isolates are as follows: erythromycin and clindamycin, ≥1 μg/ml; tetracycline, ≥8 μg/ml.